AONN+ and Manta Cares Bring Cancer-Specific AI to 9,000 Navigators
The partnership equips oncology nurse and patient navigators with purpose-built AI tools and training as cancer patients turn increasingly to general AI.
A new partnership between the Academy of Oncology Nurse and Patient Navigators (AONN+) and health technology company Manta Cares will deliver cancer-specific artificial intelligence tools, training, and educational resources to more than 9,000 oncology navigators across the United States.
The collaboration comes as cancer patients are turning in growing numbers to general-purpose AI platforms for medical information — tools that were not designed with oncology accuracy or patient safety in mind. The partnership is intended to address that gap by giving navigators access to AI built specifically for the complexities of cancer care.
Read more EastGroup Properties Names Two New Board Directors →
Oncology navigators serve as a critical link between patients and the broader healthcare system, helping individuals manage diagnoses, treatment plans, and logistical barriers. Equipping that workforce with validated, disease-specific AI is aimed at improving the guidance navigators can offer patients who may already be consuming unvetted AI-generated health content.
The agreement reflects a broader trend in healthcare toward specialty-focused AI applications, as clinicians and patient advocates push back against the use of general consumer tools in high-stakes medical settings. By embedding purpose-built AI into navigator workflows, AONN+ and Manta Cares aim to standardize safe information delivery at a scale that reaches thousands of care touchpoints nationwide.
Continue reading at GlobeNewswire - Industry News on Financial Services.
